A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

NCT07249632 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Ocular

Interventions

DRUG: Telitacicept
DRUG: Placebo

Sponsor

RemeGen Co., Ltd.

Collaborators

[object Object]
[object Object]